FdaApplication
NDA 215033
Identifiers
- fda_app_no: NDA215033
Properties
| Property | Value |
|---|---|
| applicant_name | APOTEX INC |
| application_type | NDA |
| approval_date | 2022-12-07 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BENDAMUSTINE HYDROCHLORIDE | BENDAMUSTINE HYDROCHLORIDE | 100MG/4ML (25MG/ML) | SOLUTION;INTRAVENOUS |
1 product